70 Results

People

  1. Salles
    Salles
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Shah
    Shah
  5. Lesokhin
    Lesokhin
  6. Levine
    Levine
  7. Mailankody
    Mailankody
  8. Zelenetz
    Zelenetz
  9. Abdel-Wahab
    Abdel-Wahab
  10. Derkach
    Derkach

Groups

  1. Department of Medicine (70)
  2. Hematologic Malignancies, Division of (70)
  3. Center for Hematologic Malignancies (59)
  4. Adult Leukemia (24)
  5. Survivorship Research (22)
  6. GSK Faculty (21)
  7. Bone Marrow Transplant (17)
  8. Executive Committee, Center for Hematologic Malignancies (16)
  9. Human Oncology and Pathogenesis Program (16)
  10. Epidemiology and Biostatistics (15)
  1. "human"
  2. "Hematologic Malignancies, Division of"
  3. "Research letter"
Formats
  1. Research Letter (70)
Groups
  1. Department of Medicine (70)
  2. Hematologic Malignancies, Division of (70)
  3. Center for Hematologic Malignancies (59)
  4. Adult Leukemia (24)
  5. Survivorship Research (22)
  6. GSK Faculty (21)

More Groups

People
  1. Gilles Salles (8)
  2. Heather Landau (7)
  3. Ross Levine (7)
  4. Sergio Giralt (7)
  5. Urvi Shah (7)
  6. Ahmet Dogan (6)

More People

Years
  1. 2024 (7)
  2. 2023 (24)
  3. 2022 (16)
  4. 2021 (6)
  5. 2020 (12)
  6. 2019 (5)
Publications
  1. Leukemia (14)
  2. Blood Advances (7)
  3. Bone Marrow Transplantation (7)
  4. Haematologica (7)
  5. Leukemia and Lymphoma (7)
  6. American Journal of Hematology (5)

More Publications

Publishers
  1. Nature Publishing Group (26)
  2. American Society of Hematology (11)
  3. Ferrata Storti Foundation (7)
  4. Taylor & Francis Group (7)
  5. John Wiley & Sons (5)
  6. John Wiley & Sons, Inc. (4)

More Publishers

Results (70)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesis
    Research Letter

    Sui, P.; Ge, G.; Chen, S.; Bai, J.; Rubalcava, I. P.; Yang, H.; Guo, Y.; Zhang, P.; Li, Y.; Medina, E. A.; more...
    Leukemia (2024)

    Fulltext@MSK | Save
  • Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study
    Research Letter

    Castro, F.; Parikh, R.; Eustaquio, J. C.; Derkach, A.; Joseph, J. M.; Lesokhin, A. M.; Usmani, S. Z.; Shah, U. A.
    Leukemia (2024)

    Fulltext@MSK | Save
  • Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos
    Research Letter

    Zala, M.; Lipinski, B.; Costechareyre, C.; Jarrosson, L.; Teinturier, R.; Julia, E.; Lacourrè€ge, M.; Verney, A.; Guitton, J.; Traverse-Glehen, A.; more...
    Leukemia (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1
    Research Letter

    Crosswell, H. E.; LaCasce, A. S.; Bartlett, N. L.; Straus, D. J.; Savage, K. J.; Zinzani, P. L.; Collins, G. P.; Fanale, M.; Fenton, K.; Dong, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
    Research Letter

    Paudel, B. B.; Tan, S. F.; Fox, T. E.; Ung, J.; Golla, U.; Shaw, J. J. P.; Dunton, W.; Lee, I.; Fares, W. A.; Patel, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Research Letter

    Badar, T.; Nanaa, A.; Atallah, E.; Shallis, R. M.; Guilherme, S. D. C. C.; Goldberg, A. D.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; DuVall, A. S.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schòˆder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save